Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |